Jan 21–24, 2024 | Keystone Resort, Keystone, CO, United States
Scientific Organizers:
Ryan Potts and Michelle R. Arkin

-
Scientific Organizers: Ryan Potts and Michelle R. Arkin
Ryan Potts
Michelle R. Arkin
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Booking Function
Fundraising
Sunday, January 21, 2024
Monday, January 22, 2024
Targeting Ubiquitin Ligases: From Hormones to Metabolites
Structural Mechanisms of Dynamic Multiprotein E3 Ligases
Novel Cullin-RING E3 Ligase Mechanisms Discovered through Deciphering Pathways Underlying Cellular Differentiation
Developing Targeted Deubiquitination: Opportunities for Therapeutic Protein Stabilization
Short Talk: Short Talk: Unexpected Discoveries Through Developing BTK PROTACs
Short Talk: Short Talk: Developing Discovery Proteomics Technologies to Elucidate HLA Neoantigen Presentation
Drugging the Autophagy-Lysosomal Pathway
RNATACs: Targeted mRNA Degradation
Short Talk: Short Talk: Bifunctional Small Molecules that Induce Nuclear Localization and Targeted Transcriptional Regulation
Short Talk: Short Talk: Autophagy Receptor-inspired Antibody-fusion Proteins for Targeted Intracellular Degradation
Tuesday, January 23, 2024
Modulating 14-3-3 Interactome
Targeting the Oncogenic State of RAS Mutants with Tricomplex Inhibitors
From Mutations to Molecules: Lessons Learned from Protein Phosphatase 2A
Short Talk: Short Talk: Rationally Designed Bifunctional Ligands Induce Intracellular Precipitation of Symmetric Protein Targets
Professor & Chair, Codirector, Small Molecule Discovery Center (SMDC)
Professor of Structural Biology, Head of School (Molecular Biosciences)
Principal Scientist II
Assistant Research Physician
Editor-in-Chief
Towards Rational Design of Selective Protein Degraders
Teaching CRBN New Tricks
Activation of the SLFN12 RNase by Velcrin-Induced PDE3A-SLFN12 Complex Formation
Short Talk: Short Talk: Design of Programmable Peptide-Guided Proteome Editors via Generative Language Models
Wednesday, January 24, 2024
Reimagining Druggability Using Chemoproteomic Platforms
Protein Editing using Small Molecules
Targeted Ubiquitylation and Dephosphorylation of Proteins Through Proximity-Induction
Short Talk: Short Talk: Development of Haptenizing Chimeras from Known Drugs for Cancer Immunotherapy
Short Talk: Short Talk: Hijacking the Transcriptional Activation Potential of BAF for Novel Therapeutic Opportunities
Induction of Complexes Between Cyclophilin A and GTP-Bound RAS(ON) Enable Covalent Modification of KRAS(G12D) for Inhibition of G12D-Mutant Cancer Growth
CRISPR Screen Reveals BRD2/4 Molecular Glue Degrader Via Recruitment of DCAF16
Employing Membrane-bound E3 Ligases for Targeted Degradation of Cell Surface Proteins using SureTACs Technology
Improving Anti-tumor Responses by Degrading Proteins that Impose T Cell Exhaustion
New Mechanism for Protein Degradation Therapeutics
Expanding the Target Space of Molecular Glue Degraders
Global Proteome Rewiring by Fragment Electrophiles
Short Talk: Short Talk: Discovery of Novel Molecular Glue Degraders
Short Talk: Short Talk: Systematic Remodeling of Protein-Ligand Surfaces for Prospective Molecular Glue Discovery
Thursday, January 25, 2024
Subscribe for Updates